Quantcast
Last updated on April 19, 2014 at 8:32 EDT

Latest Dopamine agonists Stories

2013-03-19 12:28:16

Data from a non-interventional, observational study of 76 patients presented at the 65th American Academy of Neurology Annual Meeting ATLANTA, March 19, 2013 /PRNewswire/ -- UCB today announced data from a non-interventional, observational study conducted in Germany that found that when Parkinson's disease (PD) patients were switched from an oral PD medication to Neupro(®) (Rotigotine Transdermal System), they reported improvements in pre-existing gastrointestinal (GI) symptoms....

2013-03-07 16:23:46

Marijuana Remains Most Commonly Detected; Oral Fluid Finding More Positives MADISON, N.J., March 7, 2013 /PRNewswire/ -- Job candidates subject to pre-employment drug screening tested positive for illicit drugs at a greater rate in the first six months of 2012 than in all of 2011, according to Drug Testing Index(TM) (DTI) data released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The positivity rate from pre-employment...

Social Isolation In Adolescence Can Lead To Addiction
2013-01-24 06:19:04

Alan McStravick for redOrbit.com - Your Universe Online Addiction is a serious disorder of the brain that is characterized by a chronic and compulsive need to take a substance, typically with an increase in dosage and frequency. Someone suffering from addiction will continue their behavior even in the face of negative consequences. The root cause of addiction is not specifically known, however. A new study out of the University of Texas at Austin (UT) may just point to one indicator of...

2012-12-05 08:26:02

ATLANTA, Dec. 5, 2012 /PRNewswire/ -- Health expert and patient advocate Dr. Donnica Moore and global biopharmaceutical company UCB, Inc. are launching Choose Your Move: Take Control of RLS to shed light on the real impact of Restless Legs Syndrome (RLS) and empower those living with the disease to work with their doctor to find a treatment approach that's right for them. "Unfortunately, many people do not fully understand what it's like to live with the disease," says Dr. Moore. "RLS can...

2012-09-20 14:23:56

ROCHESTER, Minn., Sept. 20, 2012 /PRNewswire-USNewswire/ -- For far too many people, the symptoms are all-too familiar: uncomfortable, even painful, sensations in the legs while at rest. Tingling, twitching, throbbing or "antsy" feelings in the calves or thighs and even arms that make you want to get up, stretch, and move around. While these sensations can be hard to describe, the diagnosis isn't. It's called Restless Legs Syndrome (RLS/WED, or Willis-Ekbom disease) - and it affects...

2012-09-09 23:03:09

Advantage Testing in Beaumont, Texas educates consumers on the dangers and laws regarding a new synthetic drug with the street name "Bath Salts" and advises employers that the company now provides testing for this illegal substance. (PRWEB) September 08, 2012 Advantage Testing, a leading provider of workplace drug testing in Beaumont, Texas, recently decided to create awareness about the use of a fairly new synthetic drug that goes by the street name "Bath Salts." In an increased effort to...

2012-07-15 18:20:20

BRUSSELS and ATLANTA, July 16, 2012 /PRNewswire/ -- UCB announced today that Neupro(®) (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro(®) was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome. Neupro(®) improves motor function and activities of daily living in patients with PD and provides effective...

2012-06-25 02:26:15

MORRISTOWN, N.J., June 25, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules CII, (hereafter referred to as Mixed Amphetamine Salts ER Capsules), in all available strengths: 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg....

2012-06-21 23:02:01

A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson´s disease (PD) regimen, significantly improved the duration of the drugs´ effectiveness in people with advanced PD, according to research led by Dr. C. Warren Olanow at Mount Sinai School of Medicine. New York, NY (PRWEB) June 21, 2012 A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson´s disease (PD) regimen, significantly improved the duration of the drugs´ effectiveness...

2012-06-18 02:27:06

DUBLIN, June 18, 2012 /PRNewswire/ -- Today Abbott (NYSE: ABT) announced results from five abstracts evaluating levodopa-carbidopa intestinal gel (LCIG), its investigational compound for advanced Parkinson's disease. The abstracts include the results from the second interim analysis of a long-term safety and tolerability trial, as well as secondary endpoint analyses from the Phase 3 pivotal trial. All of the abstracts were presented at The 16th International Congress of Parkinson's Disease...